Download Document 8493486

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Middle East respiratory syndrome wikipedia , lookup

Bovine spongiform encephalopathy wikipedia , lookup

Bioterrorism wikipedia , lookup

Marburg virus disease wikipedia , lookup

Meningococcal disease wikipedia , lookup

Sexually transmitted infection wikipedia , lookup

Onchocerciasis wikipedia , lookup

Chagas disease wikipedia , lookup

Schistosomiasis wikipedia , lookup

Neglected tropical diseases wikipedia , lookup

Leptospirosis wikipedia , lookup

Leishmaniasis wikipedia , lookup

Visceral leishmaniasis wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Pandemic wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Syndemic wikipedia , lookup

Transcript
No paper
available
Theme:
Aquaculture
Session:
WeA2 - Pests and deseases
Title:
Counting the current costs of salmonid disease free status in
the UK
Author(s):
Abdulai Fofana , Dominic Moran
Abstract:
This paper describes the assumptions, scenarios and calculations
underlying best estimates of the current costs of three notifiable fish
diseases in the United Kingdom: infectious salmon anaemia (ISA),
viral haemorrhagic septicaemia (VHS) and infectious haemorrhagic
necrosis (IHN). The benefits of avoiding a major disease outbreak are
effectively the return on spending to maintain disease free status.
Current costs of salmonid disease freedom are the costs associated
with the efforts of control, surveillance and monitoring activities from
both the private and public sectors. The simulated effects of disease
outbreak and avoidance costs on the public sector, domestic
consumers, exporters are analysed and factored to generate
estimates of maintaining disease freedom. The estimates of the
average current costs of maintaining disease freedom per annum in
the study period ranges between £13.5 million to £23.6 million per
annum in total for all diseases. Individual current disease costs are
substantially lower if specific expenditure is dedicated to the control
and surveillance of the diseases in the private sector.